Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chemical Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1181035C enables high-purity NSAID intermediate production with reduced costs and scalable resolution processes for global supply chains.
Advanced patent CN101928301B details a novel configuration inversion method for levofosfomycin production, offering significant cost reduction and high purity for pharmaceutical manufacturers.
Patent CN104945345A details low-cost benzoin route for chiral morpholine synthesis offering significant supply chain stability and cost advantages for global buyers.
Novel chemical route for L-norvaline from n-butyraldehyde. Offers high purity and scalability for Perindopril manufacturing. Ideal for API supply chains.
Advanced chemical resolution process for L-Valine and D-Valine using DBTA. Delivers >98% optical purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN109534957B details a scalable chemical resolution route for S-(-)-2-methyl-3-phenyl-1-propanol, offering significant cost reduction and supply chain stability for chiral intermediates.
Patent CN103626668A offers high-efficiency resolution for S-pregabalin. Enhances supply chain reliability and reduces manufacturing costs significantly.
Patent CN103342676A reveals high-purity D-tryptophan synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113072480A reveals a scalable chemical resolution route for chiral (-)-5-azaspiro[2.4]heptane-7-alcohol, offering superior purity and cost efficiency for API manufacturing.
Novel chemical synthesis of L-norvaline from n-butyraldehyde offers cost-effective, scalable production for Perindopril intermediates, surpassing traditional fermentation limits.
Patent CN108239091B details a novel chemical resolution for NLG919 precursors, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111548383B details a scalable chemical resolution route for NMN, offering cost reduction in nutraceutical manufacturing and enhanced supply chain reliability.
Novel chemical resolution method for 1-R-3-fluoropiperidine-4-carboxylic acid replacing expensive chromatography with scalable Mitsunobu esterification.
Patent CN101838282B details a cost-effective resolution method for 4-AA, avoiding expensive catalysts for reliable pharmaceutical intermediate supply.
Patent CN104058935B details high-purity synthesis route. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Novel chemical route for D-norvaline from n-pentanoic acid offers cost reduction in API manufacturing and high purity for chiral drug synthesis.
Discover advanced manufacturing of chiral 1,4-dihydro-4-(3-nitrophenyl)-3,5-pyridinedicarboxylates. A robust resolution process for calcium antagonist intermediates ensuring high purity and supply stability.
Patent CN103497145B details a scalable chiral resolution process for donepezil intermediates, offering high purity and cost-effective supply chain solutions for pharmaceutical manufacturing.